Komori
Toho Acetylene (4093) · RiskMitigated

Market Price Fluctuation Risk of Held Investment Securities

First written in FY2017. 7 of 19 entries say "Mitigated", first in FY2023. Latest entry: FY2026.

19entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2017MaterialisedFY2019 – FY2020OtherFY2021-Q2 – FY2022-Q1MaterialisedFY2022-Q3 – FY2023-Q3MitigatedFY2023 – FY20262017: 120172018: 020182019: 220192020: 220202021: 220212022: 420222023: 420232024: 220242025: 120252026: 12026
Same theme, other companies
Risk from changes in the market prices of financial instruments heldA theme 389 companies write about · 387 as a headwind · 2 as a tailwind

Toho Acetylene moved to the "Worse" side of this theme in 2019, the same year as the typical company in this theme.

The whole theme swung hardest in 2019: 57 of 139 companies on the "Worse" side.

30 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 197 companies compared. The sentences above are computed from all 197.Comparing 200 of the theme's 392 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026MitigatedAnnual report

    「The valuation difference on other securities increased from ¥53,449 thousand at the end of the previous consolidated fiscal year to ¥86,130 thousand at the end of the current consolidated fiscal year.」

    The valuation difference related to market price fluctuation risk increased from the end of the previous fiscal year, showing a move toward improvement from the deterioration in valuation in the previous fiscal year.
  2. FY2026-H1MitigatedAnnual report

    「Valuation difference on other securities 53,449 64,077」

    The valuation difference on other securities increased from ¥53.449 million at the end of the previous consolidated fiscal year to ¥64.077 million at the end of the interim period, reducing the deterioration in valuation caused by market price movements from the end of the previous fiscal year.
  3. FY2025-H1MitigatedAnnual report

    「Valuation difference on other securities 57,814 70,807」

    The valuation difference on other securities increased from ¥57.814 million at the end of the previous fiscal year to ¥70.807 million at the end of the interim period, further improving the valuation difference from the end of the previous fiscal year.
  4. FY2024MitigatedAnnual report

    「Valuation difference on other securities 2,321 57,814」

    The valuation difference on other securities increased from ¥2.321 million at the end of the previous fiscal year to ¥57.814 million, further reducing the deterioration in valuation caused by market price movements through the previous fiscal year.
  5. FY2024-Q2Further increase in valuation differenceAnnual report

    「Valuation difference on other securities 2,321 30,141」

    The valuation difference on other securities increased from ¥2,321 thousand at the end of the previous fiscal year to ¥30,141 thousand at the end of the second quarter, further reducing the deterioration in valuation caused by market price movements through the previous fiscal year.
  6. FY2024-Q1Unrealized valuation gains increasedAnnual report

    「Valuation difference on other securities 2,321 27,648」

    The valuation difference on other securities increased from ¥2,321 thousand at the end of the previous fiscal year to ¥27,648 thousand, indicating a reduction in the deterioration in valuation caused by market price movements through the previous fiscal year.
  7. FY2023MitigatedAnnual report

    「Valuation difference on other securities 1,011 2,321」

    The valuation difference on other securities increased from ¥1,011 thousand at the end of the previous fiscal year to ¥2,321 thousand, indicating a reduction in the deterioration in valuation caused by market price movements through the previous fiscal year.
  8. FY2023-Q3WorsenedAnnual report

    「Valuation difference on other securities 1,011 - 24,980」

    The valuation difference on other securities declined from ¥1,011 thousand at the end of the previous fiscal year to negative ¥24,980 thousand, with the deterioration in valuation due to market price movements reflected further in net assets.
  9. FY2023-Q2WorsenedAnnual report

    「Valuation difference on other securities 1,011 - 14,823」

    The valuation difference on other securities declined from ¥1,011 thousand at the end of the previous fiscal year to negative ¥14,823 thousand at the end of the second quarter, with the deterioration in valuation due to market price movements reflected in net assets.
  10. FY2023-Q1MaterialisedAnnual report

    「Valuation difference on other securities 1,011 - 2,285」

    The valuation difference on other securities declined from ¥1,011 thousand at the end of the previous fiscal year to negative ¥2,285 thousand at the end of the first quarter, reflecting the impact of market price movements in net assets.
  11. FY2022MaterialisedAnnual report

    「Loss on valuation of investment securities, ¥11 million」

    Due to fluctuations in the market prices of listed shares and other securities, the company recognized a ¥11 million loss on valuation of investment securities, and the valuation difference on available-for-sale securities also decreased from ¥64.68 million at the end of the previous fiscal year to ¥1.01 million.
  12. FY2022-Q3MaterialisedAnnual report

    「Valuation difference on available-for-sale securities 64,680 20,127」

    The valuation difference on available-for-sale securities decreased from ¥64.680 million at the end of the previous consolidated fiscal year to ¥20.127 million at the end of the third quarter, with valuation changes in investment securities held reflected in net assets.
  13. FY2022-Q1Valuation differences on securities decreasedAnnual report

    「Valuation difference on available-for-sale securities 64,680 39,335」

    The valuation difference on available-for-sale securities decreased from ¥64.680 million at the end of the previous consolidated fiscal year to ¥39.335 million at the end of the first quarter.
  14. FY2021-Q3Valuation difference on securities increased furtherAnnual report

    「Valuation difference on available-for-sale securities 7,806 19,402」

    The valuation difference on available-for-sale securities increased from ¥7.806 million at the end of the previous consolidated fiscal year to ¥19.402 million, with valuation changes in investment securities held reflected in net assets.
  15. FY2021-Q2Increase in valuation difference on available-for-sale securitiesAnnual report

    「Valuation difference on available-for-sale securities 7,806 15,203」

    The valuation difference on available-for-sale securities increased from ¥7.806 million at the end of the previous consolidated fiscal year to ¥15.203 million, with valuation changes in investment securities held reflected in net assets.
  16. FY2020MaterialisedAnnual report

    「The main factors were an increase from investment in property, plant and equipment, offset by a decrease due to depreciation expense and a decline in investment securities resulting from lower fair values of listed shares.」

    The decline in the fair value of listed shares was reflected in the full-year financial position as a decrease in investment securities.
  17. FY2020-Q2MaterialisedAnnual report

    「Valuation difference on available-for-sale securities 82,187 58,478」

    The valuation difference on available-for-sale securities decreased from ¥82.187 million at the end of the previous consolidated fiscal year to ¥58.478 million, with valuation changes in investment securities held reflected in net assets.
  18. FY2019MaterialisedAnnual report

    「Investment securities decreased due to a decline in the fair value of listed shares.」

    The decline in listed share prices was reflected in the financial statements as a decrease in investment securities.
  19. FY2017First statedAnnual report

    「Investment securities consist of shares, and listed shares are exposed to the risk of fluctuations in market prices. They are primarily shares in companies with which we have business relationships, and their fair values, monitored quarterly, are reported to the Board of Directors.」

    The company has for the first time explicitly identified the risk of fluctuations in market prices for listed shares, including cross-shareholdings, in the notes to the financial instruments.
Moved together

"Expansion of the automotive equipment-related business driven by growing capital investment demand from auto parts manufacturers" moved the same way as this thread, in the same document, in 7 of its 19 moves.

777544★123456
  1. ★This thread
  2. 1Expansion of the automotive equipment-related business driven by growing capital investment demand from auto parts manufacturers7×
  3. 2Risk of Inability to Pass Electricity and Crude Oil Price Increases on to Selling Prices7×
  4. 3Uncertainty in the Economic Environment Due to Concerns over China’s Economic Slowdown and the Yen’s Rapid Appreciation7×
  5. 4Revenue Decline in Other Businesses Due to Decreased Orders for Ice-Making and Refrigeration Machinery, etc.5×
  6. 5Strengthening earnings power through sales volume, appropriate pricing and cost reductions4×
  7. 6Focused Investment in the Food-Related Sector and Becoming the Market Leader4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Toho Acetylene's next results are scheduled for 2026-11-12. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.